Bluejay Diagnostics, Inc. (BJDX) Free cash flow 2021–2025
Bluejay Diagnostics, Inc. (BJDX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.2MFY2025 · since FY2021: -$4.4M → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | +23.4% |
| FY2024 | -$8.1M | +9.9% |
| FY2023 | -$9.0M | -0.9% |
| FY2022 | -$8.9M | -103.6% |
| FY2021 | -$4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BJDX financial trends
BJDX RevenueBJDX Net incomeBJDX Net marginBJDX Gross profitBJDX Gross marginBJDX Operating incomeBJDX Operating marginBJDX Operating cash flowBJDX Capital expendituresBJDX Return on equityBJDX Stock buybacksBJDX Dividends paidBJDX Total assetsBJDX Total liabilitiesBJDX Shareholders’ equityBJDX overview →